Gene therapy provides more quality-adjusted life-years versus non-myeloablative haploidentical allogeneic stem cell transplantation in sickle cell disease, but at a much higher cost. The cost of gene ...
AML: Acute myeloid leukemia; ATG: anti thymocyte globulin; BM: bone marrow; CnI: calcineurin inhibitor; MDS: Myelodysplastic syndrome; MF: myelofibrosis; MTX ...
ABO incompatibility between donor and recipient remains one of the most common immuno‐haematological challenges in allogeneic haematopoietic stem cell transplantation (HSCT). Unlike solid organ ...
Northwestern Medicine scientists have discovered how a subset of immune cells are essential for successful organ transplantation acceptance and that therapeutically targeting them may improve ...
The author(s) indicated no potential conflicts of interest. Corresponding author: Shigeo Fuji, MD, Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1, Tsukiji, ...
Hosted on MSN
Partial match parity: Increasing the donor pool for hematopoietic stem cell transplantation
Blood cancer patients who may have previously struggled to find a donor for transplantation now have more options. A new study shows that patients achieve good outcomes with a partial match drawn from ...
MD Anderson Cancer Center at Cooper now offers stem cell transplants in Camden, potentially saving patients trips to ...
A pioneering clinical trial has successfully enabled three patients with end-stage kidney disease to receive previously ...
NMDP SM, the nonprofit organization that operates the national registry of unrelated bone marrow donors and cord blood units through the federally-authorized C.W. Bill Young Cell Transplantation ...
Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds By Dennis Thompson HealthDay ReporterWEDNESDAY, April 29, 2026 (HealthDay News) — A new way of using umbilical cord blood — ...
CAR T-cell therapy successfully cleared anti-HLA antibodies to enable kidney transplantation in three highly sensitized ...
A pioneering clinical trial has successfully enabled two patients with end-stage kidney disease to receive previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results